|
Latest Communications |
|
|
|
The principal elements of our business strategy are:
We expect to focus a substantial portion of our efforts on the further development, approval and commercialization of our existing portfolio of product candidates.
portfolio of product candidates.A key element of our partnering strategy is to enter into license agreements with leading corporations to commercialize our product candidates in most of the countries worldwide
We intend to build our future product pipeline by stimulating internally driven
innovation as well as through in-licensing and/or acquisition of select proprietary product candidates and/or new proprietary
technology platforms primarily in the oral and topical fields;
While maintaining overall internal control and management of the planning, execution, development and regulatory processes, we seek to enter into strategic partnerships to boost development of our product candidates: such partnerships include collaborative arrangements with technology, manufacture, and/or know how providers;
Click here to see our current partnership arrangements.We intend to continue to offer value added development services to pharmaceutical companies under contract and helping them to develop their own product pipeline.
The Company is structured and organized as a centrally managed, vertically Integrated, global product development company and it is positioned as a one stop shop for all R&D and regulatory activities.
We have positioned APR as preferred
General Contractor
able to manage, execute and supervise the entire development project on behalf of our clients.
